
Envision Pharma Group
Global provider of evidence-based communication services and industry-leading technology solutions serving pharmaceutical, biotech & medical device companies.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | Buyout | ||
Total Funding | 000k |
Related Content
Envision Pharma Group operates in the life sciences sector, providing a comprehensive suite of services and technology solutions to support clients across the product life cycle. The company specializes in medical communications, commercialization, strategic consulting, and value access. Envision leverages advanced technologies such as artificial intelligence and natural language processing to enhance its service offerings. The company serves a diverse range of clients, including pharmaceutical companies, biotech firms, and healthcare organizations. Its business model revolves around offering tailored solutions that integrate scientific expertise with delivery excellence. Envision generates revenue through service contracts, consulting fees, and technology solutions. The company is particularly recognized for its capabilities in the Asian Pacific region through its ProScribe division, which is known for its medical communication services.
Keywords: life sciences, medical communications, AI, consulting, commercialization, biotech, healthcare, strategic solutions, ProScribe, technology.
Tech stack
Investments by Envision Pharma Group
Edit




